Wavefront-guided retreatment after primary wavefront-guided laser in situ keratomileusis in myopes and hyperopes: long-term follow-up.
OBJECTIVE
To assess the long-term safety, predictability, and efficacy of wavefront-guided laser in situ keratomileusis (LASIK) retreatment in myopes and hyperopes following primary wavefront-guided LASIK.


METHODS
Retrospective nonrandomized case series.


METHODS
Wavefront-guided retreatment was performed by a single surgeon (D.G.). A cohort of 63 eyes of 41 patients were studied, investigating refractive outcome, uncorrected visual acuity (UCVA), and best-corrected visual acuity before and after wavefront-guided LASIK retreatment.


RESULTS
The mean spherical equivalent (MSE) prior to primary LASIK in the myopic group (46 eyes) was -5.4 +/- 2.5 diopters (D) (range, -1 to -11.25 D). After the final retreatment the MSE was -0.08 +/- 0.45 D (range, +1.25 to -1.25) with 82.6% achieving +/-0.5 D and 95.6% +/-1 D of emmetropia. The initial MSE in the hyperopic group (17 eyes) was +1.91 +/- 1.13 D (range, +0.25 to +5.73 D). After the final retreatment the MSE was +0.23 +/- 0.43 D (range, -0.5 to +1.25) with 88.2% achieving +/-0.5 D and 100% +/-1 D of emmetropia. Logarithm of the minimal angle of resolution UCVA was 0.22 +/- 0.21 prior to primary LASIK and -0.06 +/- 0.13 after final retreatment for myopes and 0.14 +/- 0.15 prior to primary LASIK and 0.06 +/- 0.16 after final retreatment for hyperopes. The mean follow-up time after LASIK enhancement was 17.75 months in the myopic and 14.6 months in the hyperopic group.


CONCLUSIONS
Our results suggest that wavefront-guided retreatment following initial wavefront-guided treatment in myopes and hyperopes has favorable outcome with respect to safety, predictability, and efficacy.
Kashani
Shahram
S
Department of Ophthalmology, Moorfields Eye Hospital, London, United Kingdom. shahdoc@hotmail.com
Rajan
Madhavan
M
Gartry
David
D
D000328:Adult; D000368:Aged; D001251:Astigmatism / Q000503:physiopathology; D003315:Cornea / Q000503:physiopathology / Q000601:surgery*; D019781:Corneal Topography; D005139:Eyeglasses; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006956:Hyperopia / Q000503:physiopathology / Q000601:surgery*; D020731:Keratomileusis, Laser In Situ / Q000379:methods*; D054018:Lasers, Excimer / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009216:Myopia / Q000503:physiopathology / Q000601:surgery*; D017060:Patient Satisfaction; D012086:Reoperation; D012189:Retrospective Studies; D016896:Treatment Outcome; D014792:Visual Acuity / Q000502:physiology